Halberd Corporation (OTCMKTS:HALB) Stock To Watch: Company Creates Subsidiary to Apply Its Patented Technology to Treat Cancer
Halberd Corporation (OTCMKTS:HALB) has been one of the healthcare companies which has been publishing its research work related to its patented extracorporeal treatment methodology in recent times and has made considerable progress. The company has demonstrated that the process could be deployed to combat a wide range of medical conditions and this morning Halberd made another significant announcement that investors could take a look into. The company announced this morning…